Skip to main content

Military Health System

New Opioid Antidote Prescriptions are Making Pain Management Safer

Image of Airman holding a box of Narcan, an opioid overdose antidote called naloxone, in her hands. Airmen at the 178th Wing were given naloxone (Narcan) through Project DAWN to use in case they encounter someone experiencing an opioid overdose May 6, 2019, at Springfield Air National Guard Base, Ohio. Project DAWN (Deaths Avoided with Naloxone) educates personnel on the opioid epidemic and teaches them how to administer naloxone in an effort to help reduce opioid overdoses.

Recommended Content:

Pain Management Toolkit | Pain Management Toolkit

Patients are not always aware that all opioids carry a risk for potentially fatal overdose. 

As such, the Military Health System is working to educate doctors and patients on the importance of naloxone to address the inherent risks associated with a type of prescription pain medications called opioids. 

“Naloxone is like a fire extinguisher in your kitchen. You don’t expect to need it while cooking dinner, but if a fire occurs there is no substitute for having it nearby,” said Army Lt. Col. Lori Whitney, director of the Army’s Comprehensive Pain Management Program.

Naloxone is most commonly provided in the form of a nasal spray. It is an “opioid antagonist,” meaning that it blocks the effects of other opioids, such as morphine or oxycodone. The medication is a temporary treatment, so it is critical to obtain follow-on medical attention as soon as possible if an overdose occurs.

Routine prescribing of naloxone, also known as Narcan, is a relatively new practice in medicine, said Kevin Galloway, a spokesman for the Defense and Veterans Center for Integrative Pain Management, which is the DOD’s center of excellence for pain management located at the Uniformed Services University for the Health Sciences in Bethesda, Maryland.

The Military Health System has a goal to prescribe naloxone to at least 90% of patients who are prescribed opioids and who also fall into any of the designated risk categories, Galloway said.

The number of prescriptions issued for naloxone has significantly increased during the past several years, according to military health records.

In addition to co-prescribing naloxone, MHS providers and pharmacists provide patients with information on the safe use, storage, and disposal of opioids as well as overdose prevention.

This two-pronged approach also involves educating family members about naloxone since they are the ones most likely to administer this antidote in the event of an overdose.

Naloxone is used to revive patients whose breathing has become extremely slow or stopped due to possible opioid overdose. While naloxone comes with clear instructions, it is very important that family members or roommates are educated on the signs of opioid overdose and naloxone administration in advance of any emergency.

“In the MHS, our providers and pharmacists work together in a system of checks and balances, assessing the individual patient’s risk factors, with either able to provide the naloxone and opioid safety education when indicated,” Whitney said.

Naloxone was approved by the Food and Drug Administration in the 1970s, and is available at military medical treatment facility pharmacies throughout the world, and is also available without a prescription at many commercial pharmacies.

It is also possible to get naloxone from community-based distribution programs, local public health groups, or local health departments, free of charge.

You also may be interested in...

Comprehensive Policy on Pain Management by the Military Health Care System

Congressional Testimony
12/20/2019

HR 2647, NDAA Conference Report for FY 2010, Sec. 711

Recommended Content:

Pain Management Toolkit

Opioid Abuse and Non-Opiate Pain Management

Congressional Testimony
7/12/2019

H.R. 6157, HAC Report for FY 2019, 115-769, Pg. 298

Recommended Content:

Pain Management Toolkit | Pain Management Toolkit
Showing results 1 - 2 Page 1 of 1
Refine your search
Last Updated: September 02, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery